Press Releases

FINDLAY, Ohio--(BUSINESS WIRE)-- Cooper Tire & Rubber Company (NYSE: CTB) today announced that Christopher J. Eperjesy will join the company as Senior Vice President & Chief Financial Officer effective Dec. 10. Eperjesy will succeed Ginger M. Jones, who as previously announced, is retiring. This press release features multimedia. View the full release here:

Read more...

OKLAHOMA CITY & DALLAS--(BUSINESS WIRE)-- Xpress Wellness Urgent Care (“Xpress”), the largest urgent care provider to secondary markets in Oklahoma and Kansas, today announced that it has received an investment from Latticework Capital Management (“LCM”), a Dallas-based growth-oriented private equity firm focused exclusively on the healthcare industry. Financial terms of the transaction wer

Read more...

CHARLOTTE, N.C.--(BUSINESS WIRE)-- SentryOne has onboarded a new Software Development Engineering team out of its Dublin City Centre, Ireland, office to accommodate their rapidly-growing EMEA footprint. Since opening in May 2018, the Irish subsidiary has quickly become entrenched in the EMEA Microsoft Data Platform community. “Dublin was an obvious choice for the location of our EMEA office due

Read more...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cadent Therapeutics, a company focused on the development of breakthrough therapies to improve the lives of patients with movement and cognitive disorders, today announced that it has raised $40 million in a Series B financing. In addition, the company has appointed Bob (Ibrahim) Dagher, M.D., as Chief Medical Officer. “In a short amount of time, Cadent has a

Read more...

CHICAGO--(BUSINESS WIRE)-- R.R. Donnelley & Sons Company (RRD) (NYSE:RRD), a leading global provider of multichannel solutions for marketing and busin

Read more...

ATLANTA & MELVILLE, N.Y.--(BUSINESS WIRE)-- Today, UCB, a global biopharmaceutical company working in Parkinson’s disease (PD) and other chronic illne

Read more...

DEDHAM, Mass.--(BUSINESS WIRE)-- The Norfolk & Dedham Group, a property and casualty insurance company headquartered in Dedham, Mass., has partnered with

Read more...

RICHMOND, Va.--(BUSINESS WIRE)-- Compare.com, the only website dedicated to accurately comparing multiple auto insurance companies at once, has analyzed data from more than 2.3 million American drivers to identify key factors that influence car insurance premiums for drivers. The

Read more...

MIAMI--(BUSINESS WIRE)-- CareCloud, the platform for high-growth medical groups, today announced that it has expanded its revenue cycle management (RCM) serv

Read more...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Artificial Intelligence (AI) is key to building a better health care future, according to a recent survey of 500 U.S. health care leaders on their attitudes and usage of the technologies. Most (94 percent) responded that their organizations continue to invest in and make progress in implementing AI. The inaugural OptumIQ Annual Survey on AI in Health Care

Read more...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced that management will host a

Read more...

MACAO--(BUSINESS WIRE)-- Deswell Industries, Inc. (Nasdaq:DSWL) today announced its unaudited financial results for the first six months of fiscal 2019, ended September 30, 2018. Net sales for the six months ended September 30, 2018 were $34.8 million, an increase of 16.9% compared to net sales of $29.8 million for the six months ended September 30, 2017. Net sales decreased by 1% to $13.6 mil

Read more...

PARIS & BOSTON--(BUSINESS WIRE)-- In recent analysis, Novarica, a leading insurance research, advisory and strategic consulting firm featured

Read more...

WALTHAM, Mass.--(BUSINESS WIRE)-- Visterra, Inc., a clinical stage biotechnology company, announced today that its Phase 2a study of VIS410, a novel monoclonal antibody, demonstrated safety, tolerability and clinical activity trends in non-hospitalized patients with influenza A. These data, along with in vitro data describing the antiviral activity of VIS410 in combination with small molecule antivirals

Read more...